Wednesday, June 11, 2008

Roche Updates Invirase Package Insert

June 11, 2008--Roche Laboratories, Inc. has updated their package insert for their protease inhibitor, Invirase (saquinavir) to include the following drug interaction information and include new warnings regarding coadministration of Invirase/ritonavir and digoxin (used in the treatment of various cardiac conditions).

The details can be read here.

No comments: